Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Q-Line Biotech IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Q-Line Biotech Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹
28.63 and post-issue EPS of ₹
12.06 for FY25. The pre-issue P/E ratio is
11.98x,while the post-issue P/E ratio is
28.44x against the Industry P/E ratio is
NAx The company's ROE for FY25 is
23.74% and RoNW is
23.74% The Annualised EPS is ₹
22.12x and P/E is
₹
15.51x, These metrics suggest that the IPO is Fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 28.63 |
| EPS Post IPO (Rs.) | 12.06 |
| Adjusted 12M EPS Post IPO (Rs.) | 22.12 |
| P/E Pre IPO | 11.98 |
| P/E Post IPO | 28.44 |
| Adjusted 12M P/E Post IPO | 15.51 |
| ROE | 23.74% |
| ROCE | 17.66% |
| P/BV | 2.84 |
| Debt/Equity | 0.87 |
| RoNW | 23.74% |
| EBITDA Margin | 22.73% |
| PAT Margin | 8.72% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
